Larvol Delta - Harbour-BioMedand-KelunBiotech-announced-that-the-National-Medical-Products-Administration-NMPA-of-China-has-approved-the-Investigational-New-Drug-IND-application-for-HBM7575SKB575for-the-treatment-of-asthma

HBM7575 - Harbour BioMed, Sichuan Kelun Pharma

Harbour BioMed...and Kelun-Biotech ...announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) application for HBM7575/SKB575...for the treatment of asthma. (PRNewswire) Jul 15, 2026
New trial • Asthma

https://www.prnewswire.com/news-releases/harbour-biomed-and-kelun-biotech-announce-nmpa-approval-of-ind-application-for-hbm7575skb575-for-the-treatment-of-asthma-302826305.html

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next